CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma

Author:

Rubenstein James L.1,Wong Valerie S.1,Kadoch Cigall1,Gao Hua-Xin1,Barajas Ramon2,Chen Lingjing1,Josephson S. Andrew3,Scott Brian3,Douglas Vanja3,Maiti Mekhala1,Kaplan Lawrence D.1,Treseler Patrick A.4,Cha Soonmee2,Hwang Jimmy H.5,Cinque Paola6,Cyster Jason G.7,Lowell Clifford8

Affiliation:

1. Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center,

2. Department of Radiology and Biomedical Imaging,

3. Department of Neurology,

4. Department of Pathology, and

5. Biostatistics and Computational Biology Core, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA;

6. Department of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy; and

7. Department of Microbiology and Immunology, Howard Hughes Medical Institute, and

8. Department of Laboratory Medicine, University of California, San Francisco, CA

Abstract

Key PointsCXCL13 and CXCL12 mediate chemotaxis of CNS lymphoma cells, and CXCL13 concentration in CSF is prognostic. CXCL13 plus IL-10 is highly specific for the diagnosis of CNS lymphoma.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 170 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3